Prostaglandin E1 New Aspects on Pharmacology, Metabolism and Clinical Efficacy /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Diehm, Curt. (Editor ), Sinzinger, Helmut. (Editor ), Rogatti, Waltraud. (Editor )
Formato: eBook
Lenguaje:English
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1991.
Edición:1st ed. 1991.
Materias:
Acceso en línea:https://doi.org/10.1007/978-3-642-76910-8
Tabla de Contenidos:
  • Cellular Sites of Action of Prostaglandins in the Cardiovascular System
  • On the Metabolism and Pharmacokinetics of Prostaglandin E1 Administered by Intra-arterial or Intravenous Infusions
  • Actions of PGE1 PGE0 and 15-keto-PGE1 on Vessel Tone In Vitro
  • 13,14-dihydro-PGE1 (PGE0) but not 15-keto-PGE1 is a Potent Inhibitor of Human Platelet and Neutrophil Activation
  • Comparable Inhibitory Action of PGE1 and 13–14-dihydro-PGE1 on Smooth Muscle Cell Activity and Extracellular Matrix Production
  • PGE1 and 13,14-dihydro-PGE1 Increase Low-Density Lipoprotein Receptors and Improve Arterial Wall Lipid Metabolism
  • Effect of Intra-arterial and Intravenous Application of Prostaglandin E1 on Neutrophil Function in Peripheral Arterial Occlusive Disease
  • A Comparison of Different Dosages of Intra-arterial and Intravenous Administered Prostaglandin E1 in Healthy Volunteers
  • Transcutaneous Oxygen Pressure at Different Dosages of Intravenous Prostaglandin E1 in Patients with Severe Arterial Occlusive Disease: A Double-Blind, Placebo-Controlled Study
  • Transcutaneous PO2 During Intra-arterial and Intravenous PGE1 Infusion in Patients with Critical Limb Ischaemia
  • Effects of Intravenous PGE1 on Blood Flow and Microcirculation: A Double-Blind, Placebo-Controlled Study in Patients with Critical Limb Ischaemia
  • Therapeutic Efficacy of Intravenous Prostaglandin E1 Versus Pentoxifylline in Patients with Intermittent Claudication
  • Adjuvant Intravenous PGE1 Treatment After Profundaplasty for Limb Salvage.